An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer, Colorectal Cancer, Gastric Cancer
Interventions: DRUG: Capecitabine
Sponsor: Hoffmann-La Roche